Olympus Corporation has announced a voluntary, global medical device corrective action to provide further clarification on ...

Karen McGonigal, 53, died after she was illegally administered a dose of semaglutide at a local beauty salon. A doctor and ...

People taking popular new weight-loss drugs such as Wegovy and Zepbound often celebrate the number of pounds they shed and ...

Scientists look to genetics to explain why GLP-1 drugs work for some people but not for others People taking popular new ...

Development of the latest class of incretin-based therapeutics for diabetes and obesity has been heralded as a major step ...

Denmark's Novo Nordisk said Tuesday it would replace more than half of its board, including the chair, as the Ozempic and ...

What is the ‘golden dose’ and what are the risks? Medical News Today asks four experts to weigh in on the trend of trying to get a fifth dose out of Mounjaro.

GLP-1 medications like Ozempic and Wegovy are reducing users' appetites, leading to changes in dining habits. Some restaurants are beginning to adapt by offering smaller portions and specialized menus ...

The drugmaker behind Wegovy has secured a major victory after the High Court granted it a blocking order for websites selling ...

A new study suggests GLP-1 drugs like Ozempic and Wegovy — commonly used for diabetes and weight loss — may also blunt the effects of alcohol. That might be bad news for casual drinkers, but ...

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...

Scientists are learning more about the strange effects of Ozempic and similar GLP-1 drugs on alcohol use. New research shows that these obesity and diabetes medications might actually change how our ...